Menu Menu

XLO    Xilio Therapeutics Inc    1840233    
Income Statement
Revenue xlo-20241231x10k 2,263,000
Net Income xlo-20241231x10k -14,020,000
Profit Margin -619.53%

Balance Sheet
Current Assets 63,309,000
Assets 74,658,000
Current Liabilities 38,022,000
Liabilities 53,684,000
Equity 20,974,000

Cash Flow Statement
Operating Cash Flow -4,221,000
Investing Cash Flow -30,000

Market Analysis
Price 0.79
BVPS 1.88
PB 0.41
PS 3.19
FCF -4,251,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec
11/7 -0.22

Find a discrepancy? The most accurate way to find company fundamental data is to view XLO documents filed with the SEC.


XLO Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas